ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018
ZIP4 Promotes Pancreatic Cancer Progression by Repressing ZO-1 and Claudin-1 through a ZEB1-Dependent Transcriptional Mechanism.
Open access · greenAbstract read
In one paragraph
Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.
0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
61 citing papers in PubMed, 113 citations in OpenAlex.
- Immunomagnetic-MXene Bifunctional Probes for Ultrasensitive and Specific Terahertz Metasensing of Tumor-Derived Exosomes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Mitophagy-Competent Cancer-Associated Fibroblasts Fuel Chemoresistance by Rewiring Pyrimidine Metabolism in Pancreatic Cancer.Cancer research · 2026Article
- Article
- Review
- Metal-related cell death and its application in pancreatic cancer.Expert reviews in molecular medicine · 2025Review
- Zinc-Mediated Defenses Against Toxic Heavy Metals and Metalloids: Mechanisms, Immunomodulation, and Therapeutic Relevance.International journal of molecular sciences · 2025Review
- Loss of Zonula Occludens-1 (ZO-1) Enhances Angiogenic Signaling in Ovarian Cancer Cells.International journal of molecular sciences · 2025Article
- A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- Role of solute carrier transporters in ovarian cancer (Review).International journal of molecular medicine · 2025Review
- The protective effect ofFrontiers in nutrition · 2025Article
- SLC30 (ZnT) and SLC39 (ZIP) zinc transporter families: from gatekeepers of zinc homeostasis to promoters of tumorigenesis and targets for clinical therapy.Frontiers in immunology · 2025Review
- Tight junctional protein family, Claudins in cancer and cancer metastasis.Frontiers in oncology · 2025Review
- Structure-Activity Relationship Study of Majusculamide D: Overcoming Metabolic Instability and Severe Toxicity with a Fluoro Analogue.Marine drugs · 2024Article
- ZIP4 inhibits Ephrin-B1 ubiquitination, activating Wnt5A/JNK/ZEB1 to promote liver cancer metastasis.Genes & diseases · 2024Article
- The Scribble-SGEF-Dlg1 complex regulates E-cadherin and ZO-1 stability, turnover and transcription in epithelial cells.Journal of cell science · 2024Article
- Monocarboxylate transporter 4 facilitatesiScience · 2024Article
- Emerging Perspectives in Zinc Transporter Research in Prostate Cancer: An Updated Review.Nutrients · 2024Review
- The Scribble/SGEF/Dlg1 complex regulates the stability of apical junctions in epithelial cells.bioRxiv : the preprint server for biology · 2024Article
- Article
- Functional Analysis of Membrane-Associated Scaffolding Tight Junction (TJ) Proteins in Tumorigenic Characteristics of B16-F10 Mouse Melanoma Cells.International journal of molecular sciences · 2024Article
1 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors at 6 institutions in 2 countries.
Mingyang LiuDepartment of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Jingxuan YangDepartment of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.ORCID 0000-0003-3265-161X
Yuqing ZhangDepartment of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Zhijun ZhouDepartment of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Xiaobo CuiDepartment of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Liyang ZhangDepartment of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Kar-Ming FungDepartment of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Wei ZhengDepartment of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Felicia D AllardDepartment of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.ORCID 0000-0001-9903-0944
Eric U YeeDepartment of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.ORCID 0000-0001-9643-6439
Kai DingDepartment of Biostatistics and Epidemiology, College of Public Health, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Huanwen WuDepartment of Pathology, Peking Union Hospital, Peking Union Medical College, Beijing, China.
Zhiyong LiangDepartment of Pathology, Peking Union Hospital, Peking Union Medical College, Beijing, China.
Lei ZhengThe Sidney Kimmel Comprehensive Cancer Center and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Martin E Fernandez-ZapicoDepartment of Oncology, Mayo Clinic, Rochester, Minnesota.
Yi-Ping LiDepartment of Integrative Biology and Pharmacology, the University of Texas Medical School at Houston, Houston, Texas.
Michael S BronzeDepartment of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Katherine T MorrisDepartment of Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Russell G PostierDepartment of Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Courtney W HouchenDepartment of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Jing YangDepartment of Pharmacology and Pediatrics, University of California at San Diego, La Jolla, California.
Min LiDepartment of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Min-Li@ouhsc.edu.
University of Oklahoma Health Sciences Center · USChinese Academy of Medical Sciences & Peking Union Medical College · CNUniversity of California San Diego · USJohns Hopkins University · USMayo Clinic · USTexas Medical Center · US
Funding
Tissue CoreP50CA102701 · NCI · MAYO CLINIC ROCHESTER · PI PETERSEN, GLORIA M. · 2004 to 2018
$32.7MPILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2MTUMOR RESISTANCE MECHANISMS TO ANTI-VEGF THERAPY IN PROSTATE CANCER (Sukyung Woo)P20GM103639 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI HANNAFON, BETHANY · 2012 to 2022
$21.3MMechanism of Pancreatic CarcinogenesisR01CA136526 · NCI · MAYO CLINIC ROCHESTER · PI FERNANDEZ-ZAPICO, MARTIN ERNESTO · 2009 to 2019
$3.0MPrognostic Biomarkers for ZIP4-mediated Cachexia in Pancreatic CancerR01CA203108 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI LI, MIN, LI, YI-PING · 2016 to 2020
$2.7MZIP4 is a Novel Molecular Target in Human Pancreatic CancerR01CA186338 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI FERNANDEZ-ZAPICO, MARTIN ERNESTO, LI, MIN · 2015 to 2019
$1.7MRole of Vav1 protooncogene in pancreatic cancerP20CA102701 · NCI · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI PETERSEN, GLORIA M. · 2003 to 2003
$1.5MRole of Dietary Zinc Transporter ZIP4 in Pancreatic CancerR01CA138701 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LI, MIN · 2010 to 2015
$1.5MNCI NIH HHS P50 CA102701NCI NIH HHS R01 CA136526NCI NIH HHS R01 CA138701NCI NIH HHS R01 CA186338NCI NIH HHS R01 CA203108NIDDK NIH HHS P30 DK084567NIGMS NIH HHS P20 GM103639
Abstract
PubMed holds no abstract for this paper.
Indexed as
Gene Expression Regulation, NeoplasticAnimalsCation Transport ProteinsCell Line, TumorCell MovementCell ProliferationClaudin-1Disease Models, AnimalDisease ProgressionEpithelial-Mesenchymal TransitionHeterograftsHumansImmunohistochemistryMiceModels, BiologicalNeoplasm StagingCation Transport ProteinsClaudin-1SLC39A4 protein, humanTJP1 protein, humanZEB1 protein, humanZinc Finger E-box-Binding Homeobox 1Zonula Occludens-1 Protein
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.